Oligonucleotide Solid Phase Synthesizer Market Report – Research, Industry Analysis Reports and Market Demands

Global Oligonucleotide Solid Phase Synthesizer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Oligonucleotide Solid Phase Synthesizer Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Compact Synthesizer
- 1.3.3 Large Synthesizer
1.4 Market Analysis by Throughput
- 1.4.1 Overview: Global Oligonucleotide Solid Phase Synthesizer Consumption Value by Throughput: 2021 Versus 2025 Versus 2032
- 1.4.2 Low Throughput: 1–12 Sequences per Run
- 1.4.3 Medium Throughput: 13–48 Sequences per Run
- 1.4.4 High Throughput: 49–192 Sequences per Run
- 1.4.5 Ultra-High Throughput: Above 192 Sequences per Run
1.5 Market Analysis by Amidite Capacity
- 1.5.1 Overview: Global Oligonucleotide Solid Phase Synthesizer Consumption Value by Amidite Capacity: 2021 Versus 2025 Versus 2032
- 1.5.2 4–6 Amidite Positions
- 1.5.3 7–12 Amidite Positions
- 1.5.4 13–20 Amidite Positions
- 1.5.5 Above 20 Amidite Positions
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Oligonucleotide Solid Phase Synthesizer Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Pharmaceutical Companies
- 1.6.3 Lab
1.7 Global Oligonucleotide Solid Phase Synthesizer Market Size & Forecast
- 1.7.1 Global Oligonucleotide Solid Phase Synthesizer Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Oligonucleotide Solid Phase Synthesizer Sales Quantity (2021-2032)
- 1.7.3 Global Oligonucleotide Solid Phase Synthesizer Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Oligonucleotide Solid Phase Synthesizer by Manufacturer

3.1 Global Oligonucleotide Solid Phase Synthesizer Sales Quantity by Manufacturer (2021-2026)
3.2 Global Oligonucleotide Solid Phase Synthesizer Revenue by Manufacturer (2021-2026)
3.3 Global Oligonucleotide Solid Phase Synthesizer Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Oligonucleotide Solid Phase Synthesizer by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Oligonucleotide Solid Phase Synthesizer Manufacturer Market Share in 2025
- 3.4.3 Top 6 Oligonucleotide Solid Phase Synthesizer Manufacturer Market Share in 2025
3.5 Oligonucleotide Solid Phase Synthesizer Market: Overall Company Footprint Analysis
- 3.5.1 Oligonucleotide Solid Phase Synthesizer Market: Region Footprint
- 3.5.2 Oligonucleotide Solid Phase Synthesizer Market: Company Product Type Footprint
- 3.5.3 Oligonucleotide Solid Phase Synthesizer Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Oligonucleotide Solid Phase Synthesizer Market Size by Region
- 4.1.1 Global Oligonucleotide Solid Phase Synthesizer Sales Quantity by Region (2021-2032)
- 4.1.2 Global Oligonucleotide Solid Phase Synthesizer Consumption Value by Region (2021-2032)
- 4.1.3 Global Oligonucleotide Solid Phase Synthesizer Average Price by Region (2021-2032)
4.2 North America Oligonucleotide Solid Phase Synthesizer Consumption Value (2021-2032)
4.3 Europe Oligonucleotide Solid Phase Synthesizer Consumption Value (2021-2032)
4.4 Asia-Pacific Oligonucleotide Solid Phase Synthesizer Consumption Value (2021-2032)
4.5 South America Oligonucleotide Solid Phase Synthesizer Consumption Value (2021-2032)
4.6 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Oligonucleotide Solid Phase Synthesizer Sales Quantity by Type (2021-2032)
5.2 Global Oligonucleotide Solid Phase Synthesizer Consumption Value by Type (2021-2032)
5.3 Global Oligonucleotide Solid Phase Synthesizer Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Oligonucleotide Solid Phase Synthesizer Sales Quantity by Application (2021-2032)
6.2 Global Oligonucleotide Solid Phase Synthesizer Consumption Value by Application (2021-2032)
6.3 Global Oligonucleotide Solid Phase Synthesizer Average Price by Application (2021-2032)

7 North America

7.1 North America Oligonucleotide Solid Phase Synthesizer Sales Quantity by Type (2021-2032)
7.2 North America Oligonucleotide Solid Phase Synthesizer Sales Quantity by Application (2021-2032)
7.3 North America Oligonucleotide Solid Phase Synthesizer Market Size by Country
- 7.3.1 North America Oligonucleotide Solid Phase Synthesizer Sales Quantity by Country (2021-2032)
- 7.3.2 North America Oligonucleotide Solid Phase Synthesizer Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Oligonucleotide Solid Phase Synthesizer Sales Quantity by Type (2021-2032)
8.2 Europe Oligonucleotide Solid Phase Synthesizer Sales Quantity by Application (2021-2032)
8.3 Europe Oligonucleotide Solid Phase Synthesizer Market Size by Country
- 8.3.1 Europe Oligonucleotide Solid Phase Synthesizer Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Oligonucleotide Solid Phase Synthesizer Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Oligonucleotide Solid Phase Synthesizer Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Oligonucleotide Solid Phase Synthesizer Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Oligonucleotide Solid Phase Synthesizer Market Size by Region
- 9.3.1 Asia-Pacific Oligonucleotide Solid Phase Synthesizer Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Oligonucleotide Solid Phase Synthesizer Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Oligonucleotide Solid Phase Synthesizer Sales Quantity by Type (2021-2032)
10.2 South America Oligonucleotide Solid Phase Synthesizer Sales Quantity by Application (2021-2032)
10.3 South America Oligonucleotide Solid Phase Synthesizer Market Size by Country
- 10.3.1 South America Oligonucleotide Solid Phase Synthesizer Sales Quantity by Country (2021-2032)
- 10.3.2 South America Oligonucleotide Solid Phase Synthesizer Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Market Size by Country
- 11.3.1 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Oligonucleotide Solid Phase Synthesizer Market Drivers
12.2 Oligonucleotide Solid Phase Synthesizer Market Restraints
12.3 Oligonucleotide Solid Phase Synthesizer Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Oligonucleotide Solid Phase Synthesizer and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oligonucleotide Solid Phase Synthesizer
13.3 Oligonucleotide Solid Phase Synthesizer Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Oligonucleotide Solid Phase Synthesizer Typical Distributors
14.3 Oligonucleotide Solid Phase Synthesizer Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Oligonucleotide Solid Phase Synthesizer market size was valued at US$ 253 million in 2025 and is forecast to a readjusted size of US$ 440 million by 2032 with a CAGR of 8.1% during review period.
An Oligonucleotide Solid-Phase Synthesizer is an automated or semi-automated instrument that chemically assembles DNA, RNA and modified oligonucleotides on controlled-pore glass, polystyrene or another immobilized solid support. The system repeatedly performs deprotection, phosphoramidite coupling, capping and oxidation or sulfurization cycles while controlling reagent delivery, reaction time, pressure, inert-gas protection, washing and waste discharge. The market includes compact benchtop instruments, multi-column and microplate synthesizers, solid-surface microarray platforms, process-development systems, pilot-scale equipment and GMP-oriented commercial production systems. Instruments may support primers, probes, gene-assembly fragments, aptamers, antisense oligonucleotides, small interfering RNA, locked nucleic acids and other modified sequences. Reagents, synthesis supports, columns, synthesis services, enzymatic DNA synthesis systems, purification equipment and analytical instruments are excluded. In 2025, the global weighted average selling price was approximately US$280,000 per system, global sales volume was approximately 879 systems, and average gross margin was estimated at 48%. Upstream activities include precision pumps, chemically resistant valves and tubing, reaction columns, pressure sensors, ultraviolet and conductivity detectors, industrial controllers, computers, explosion-protection components and synthesis software. Midstream activities include fluidic-system engineering, mechanical fabrication, software development, instrument assembly, method configuration, testing, validation, installation and application support. Downstream customers include oligonucleotide manufacturers, pharmaceutical and biotechnology companies, contract development and manufacturing organizations, molecular-diagnostics companies, gene-synthesis companies, universities, research institutes and genomics laboratories.
Demand is shifting from conventional primer production toward modified RNA, antisense oligonucleotides, small interfering RNA and other therapeutic sequences. These applications require more monomer positions, flexible backbone chemistry and tighter process control.
The market has two distinct equipment structures. High-throughput plate systems focus on producing many short sequences, while large flow-through column systems focus on producing fewer sequences at millimole-to-mole scale.
Process transfer is becoming an important purchasing criterion. Pharmaceutical users increasingly prefer equipment families that allow methods developed at laboratory scale to be transferred to pilot and commercial systems without completely rebuilding the synthesis process.
Online monitoring is moving beyond basic pressure alarms. Ultraviolet absorbance, conductivity, temperature, density and mass-flow measurements are increasingly used to assess detritylation, reagent delivery and process consistency.
Reagent consumption remains a major operating-cost consideration. Low-dead-volume valves, direct injection, reagent recycling and selective-drain systems can materially reduce consumption of expensive modified phosphoramidites.
Compliance requirements create a significant price difference. Research instruments may use simple local software, whereas clinical and commercial systems require user management, audit trails, electronic records, validation documentation and explosion-protection designs.
Chinese suppliers are expanding from laboratory instruments into process-development, pilot and industrial-scale systems. Their growth is supported by local oligonucleotide-drug development and demand for domestic equipment alternatives.
The principal technical risks are moisture ingress, reagent degradation, valve carryover, unequal flow between channels, insufficient washing, incorrect pressure control and incomplete method transfer. Equipment performance must therefore be evaluated together with chemistry, supports and operating procedures.
Report Scope
This report is a detailed and comprehensive analysis for global Oligonucleotide Solid Phase Synthesizer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oligonucleotide Solid Phase Synthesizer market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Oligonucleotide Solid Phase Synthesizer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Oligonucleotide Solid Phase Synthesizer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Oligonucleotide Solid Phase Synthesizer market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oligonucleotide Solid Phase Synthesizer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oligonucleotide Solid Phase Synthesizer market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, LGC Biosearch Technologies, Biolytic Lab Performance, Inc., Sierra BioSystems, Inc., K&A Labs GmbH, PolyGen GmbH, OligoMaker ApS, Kilobaser GmbH, CSBio Co., KNAUER Wissenschaftliche Geräte GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Oligonucleotide Solid Phase Synthesizer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Compact Synthesizer
Large Synthesizer
Market segment by Throughput
Low Throughput: 1–12 Sequences per Run
Medium Throughput: 13–48 Sequences per Run
High Throughput: 49–192 Sequences per Run
Ultra-High Throughput: Above 192 Sequences per Run
Market segment by Amidite Capacity
4–6 Amidite Positions
7–12 Amidite Positions
13–20 Amidite Positions
Above 20 Amidite Positions
Market segment by Application
Pharmaceutical Companies
Lab
Major players covered
Cytiva
LGC Biosearch Technologies
Biolytic Lab Performance, Inc.
Sierra BioSystems, Inc.
K&A Labs GmbH
PolyGen GmbH
OligoMaker ApS
Kilobaser GmbH
CSBio Co.
KNAUER Wissenschaftliche Geräte GmbH
PeptiSystems AB
Jiangsu Lingkun Biotechnology Co., Ltd.
Jiangsu Hanbon Science & Technology Co., Ltd.
Suzhou SePure Instruments Co., Ltd.
Beijing Tsingke Biotech Co., Ltd.
Suzhou Inscinstech Intelligent Technology Co., Ltd.
Hangzhou LinkZill Technology Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Oligonucleotide Solid Phase Synthesizer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oligonucleotide Solid Phase Synthesizer, with price, sales quantity, revenue, and global market share of Oligonucleotide Solid Phase Synthesizer from 2021 to 2026.
Chapter 3, the Oligonucleotide Solid Phase Synthesizer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oligonucleotide Solid Phase Synthesizer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oligonucleotide Solid Phase Synthesizer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oligonucleotide Solid Phase Synthesizer.
Chapter 14 and 15, to describe Oligonucleotide Solid Phase Synthesizer sales channel, distributors, customers, research findings and conclusion.

Buy now